As of September 09, 2026, the three largest insider holders of IXHL are Joel Latham (Ceo And President, 806.21K shares), Troy Valentine (Director, 400.06K shares), George Anastassov (Director, 81.89K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Joel Latham | Ceo And President | 858,789 | 0 | 858,789 | 55.0% | 14 Nov, 2025 |
| 2 | Troy Valentine | Director | 423,370 | 0 | 423,370 | 27.1% | 14 Nov, 2025 |
| 3 | George Anastassov | Director | 107,547 | 0 | 107,547 | 6.9% | 14 Nov, 2025 |
| 4 | Peter Widdows | Director | 74,288 | 0 | 74,288 | 4.8% | 14 Nov, 2025 |
| 5 | Robert Clark | Director | 62,899 | 0 | 62,899 | 4.0% | 14 Nov, 2025 |
| 6 | Joseph Swan | Cfo, Treasurer And Secretary | 30,712 | 0 | 30,712 | 2.0% | 14 Nov, 2025 |
| 7 | Luigi M. Barbato | Chief Medical Officer | 3,349 | 0 | 3,349 | 0.2% | 24 Oct, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 14 Nov, 2025 | Peter Widdows | Director | Acquired A | 1,686,956 | $0.00 | $0 | 65,260 | Direct |
| 14 Nov, 2025 | Joseph Swan | Cfo, Treasurer And Secretary | Acquired A | 869,565 | $0.00 | $0 | 30,712 | Direct |
| 14 Nov, 2025 | George Anastassov | Director | Acquired A | 1,686,956 | $0.00 | $0 | 81,889 | Direct |
| 14 Nov, 2025 | Troy Valentine | Director | Acquired A | 11,302,608 | $0.00 | $0 | 400,062 | Direct |
| 14 Nov, 2025 | Joel Latham | Ceo And President | Acquired A | 22,608,692 | $0.00 | $0 | 806,206 | Direct |
| 14 Nov, 2025 | Peter Widdows | Director | Acquired A | 1,686,956 | $0.00 | $0 | 65,260 | Direct |
| 14 Nov, 2025 | Troy Valentine | Director | Acquired A | 11,302,608 | $0.00 | $0 | 400,062 | Direct |
| 14 Nov, 2025 | Joel Latham | Ceo And President | Acquired A | 22,608,692 | $0.00 | $0 | 806,206 | Direct |
| 14 Nov, 2025 | Joseph Swan | Cfo, Treasurer And Secretary | Acquired A | 869,565 | $0.00 | $0 | 30,712 | Direct |
| 14 Nov, 2025 | Robert Clark | Director | Acquired A | 1,686,956 | $0.00 | $0 | 59,565 | Direct |
| 14 Nov, 2025 | Joseph Swan | Cfo, Treasurer And Secretary | Acquired A | 869,565 | $0.00 | $0 | 30,712 | Direct |
| 14 Nov, 2025 | Troy Valentine | Director | Acquired A | 11,302,608 | $0.00 | $0 | 400,062 | Direct |
| 14 Nov, 2025 | Peter Widdows | Director | Acquired A | 1,686,956 | $0.00 | $0 | 65,260 | Direct |
| 14 Nov, 2025 | Joel Latham | Ceo And President | Acquired A | 22,608,692 | $0.00 | $0 | 806,206 | Direct |
| 23 Oct, 2024 | Luigi M. Barbato | Chief Medical Officer | Acquired A | 100,476 | $0.00 | $0 | 3,349 | Direct |
| 21 Dec, 2023 | Robert Clark | Director | Acquired A | 100,000 | $0.00 | $0 | 3,333 | Direct |
| 21 Dec, 2023 | Peter Widdows | Director | Acquired A | 100,000 | $0.00 | $0 | 9,028 | Direct |
| 21 Dec, 2023 | Joel Latham | Ceo And President | Acquired A | 1,340,000 | $0.00 | $0 | 52,583 | Direct |
| 21 Dec, 2023 | Troy Valentine | Director | Acquired A | 670,000 | $0.00 | $0 | 23,308 | Direct |
| 21 Dec, 2023 | Joel Latham | Ceo And President | Acquired A | 1,340,000 | $0.00 | $0 | 52,583 | Direct |